Evidence map›Paper›PMID 25378499›Full record

ArticleJournal of virology2015

Class switch recombination and somatic hypermutation of virus-neutralizing antibodies are not essential for control of friend retrovirus infection.

Maiko Kato, Sachiyo Tsuji-Kawahara, Yuri Kawasaki, Saori Kinoshita, Tomomi Chikaishi, Shiki Takamura, Makoto Fujisawa, Akira Kawada, Masaaki Miyazawa

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. APOBEC3 Proteins in Viral Immunity.Journal of immunology (Baltimore, Md. : 1950) · 2015
    Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Maiko KatoDepartment of Immunology, Kinki University Faculty of Medicine, Osaka, Japan Department of Dermatology, Kinki University Faculty of Medicine, Osaka, Japan.
Sachiyo Tsuji-KawaharaDepartment of Immunology, Kinki University Faculty of Medicine, Osaka, Japan.
Yuri KawasakiDepartment of Immunology, Kinki University Faculty of Medicine, Osaka, Japan.
Saori KinoshitaDepartment of Immunology, Kinki University Faculty of Medicine, Osaka, Japan.
Tomomi ChikaishiDepartment of Immunology, Kinki University Faculty of Medicine, Osaka, Japan Unmet Medical Needs Pharma, Inc., Yokohama, Japan.
Shiki TakamuraDepartment of Immunology, Kinki University Faculty of Medicine, Osaka, Japan.
Makoto FujisawaDepartment of Immunology, Kinki University Faculty of Medicine, Osaka, Japan.
Akira KawadaDepartment of Dermatology, Kinki University Faculty of Medicine, Osaka, Japan.
Masaaki MiyazawaDepartment of Immunology, Kinki University Faculty of Medicine, Osaka, Japan masaaki@med.kindai.ac.jp.
Kindai University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Toll-like receptor 7 and Myd88 are required for antiretroviral antibody and germinal center responses, but whether somatic hypermutation and class-switch recombination are required for antiretroviral immunity has not been examined. Mice deficient in activation-induced cytidine deaminase (AID) resisted Friend virus infection, produced virus-neutralizing antibodies, and controlled viremia. Passive transfer demonstrated that immune IgM from AID-deficient mice contributes to Friend virus control in the presence of virus-specific CD4+ T cells.

Indexed as

Somatic Hypermutation, ImmunoglobulinAICDA (Activation-Induced Cytidine Deaminase)AnimalsAntibodies, NeutralizingAntibodies, ViralCD4-Positive T-LymphocytesCytidine DeaminaseFriend murine leukemia virusImmunization, PassiveImmunoglobulin Class SwitchingImmunoglobulin MLeukemia, ExperimentalMiceRetroviridae InfectionsTumor Virus InfectionsAICDA (Activation-Induced Cytidine Deaminase)Antibodies, NeutralizingAntibodies, ViralCytidine DeaminaseImmunoglobulin M

Identifiers

PMID25378499
PMCPMC4300674
OpenAlexW2135673373

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.